CN108522931A - 一种能排酸降酸溶结石调节酸碱平衡的葵花盘固体饮料 - Google Patents
一种能排酸降酸溶结石调节酸碱平衡的葵花盘固体饮料 Download PDFInfo
- Publication number
- CN108522931A CN108522931A CN201810288224.5A CN201810288224A CN108522931A CN 108522931 A CN108522931 A CN 108522931A CN 201810288224 A CN201810288224 A CN 201810288224A CN 108522931 A CN108522931 A CN 108522931A
- Authority
- CN
- China
- Prior art keywords
- parts
- acid
- sunflower disk
- base balance
- deacidification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000208818 Helianthus Species 0.000 title claims abstract description 24
- 235000003222 Helianthus annuus Nutrition 0.000 title claims abstract description 24
- 239000007787 solid Substances 0.000 title claims abstract description 16
- 235000013361 beverage Nutrition 0.000 title claims abstract description 15
- 239000002253 acid Substances 0.000 title claims abstract description 9
- 239000004575 stone Substances 0.000 title claims description 9
- 240000003915 Lophatherum gracile Species 0.000 claims abstract description 11
- 235000005918 Cirsium arvense Nutrition 0.000 claims abstract description 10
- 240000001579 Cirsium arvense Species 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 7
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 7
- 239000004480 active ingredient Substances 0.000 claims abstract description 3
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 claims 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 claims 1
- 206010056474 Erythrosis Diseases 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract description 14
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract description 13
- 229940116269 uric acid Drugs 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 9
- 230000023597 hemostasis Effects 0.000 abstract description 6
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 230000033228 biological regulation Effects 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 230000004144 purine metabolism Effects 0.000 abstract description 3
- 201000005569 Gout Diseases 0.000 abstract description 2
- 239000003907 antipyretic analgesic agent Substances 0.000 abstract description 2
- 230000036772 blood pressure Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 229930003944 flavone Natural products 0.000 description 5
- 150000002213 flavones Chemical class 0.000 description 5
- 235000011949 flavones Nutrition 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- 241001486047 Cirsium discolor Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- IKGXIBQEEMLURG-UHFFFAOYSA-N Rutin Chemical compound OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 150000002215 flavonoids Chemical group 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical group O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 150000007968 uric acids Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及保健食品领域，即一种能排酸降酸溶结晶调节酸碱平衡的葵花盘固体饮料。其有效成分由以下重量份数的原料制成：葵花盘40份—50份，淡竹叶20份—30份，小蓟20—30份，赤藓糖醇5份。组方中各成份协作用具有源头降尿酸、护肾排尿酸、溶结晶、抗炎消肿镇痛、调控嘌呤代谢、调节人体内酸碱平衡的作用。组方、制备简单，成本低。配方具有可食性，无毒副作用，安全、可靠。具有抗菌解热止痛止血等辅助作用，能够使血压血脂恢复正常。葵花盘可以有效地降低血尿酸，溶解结石，去除痛风。
Description
技术领域
本发明涉及保健食品领域，即一种能排酸降酸溶结石调节酸碱平衡的葵花盘固体饮料。
背景技术
在现有技术中,近几年来，固体饮料行业步入快速发展通道，行业内企业数量和行业产销规模不断扩大。固体饮料因品种多样、风味独特、以植物提取物为主要原料，易于存放而备受消费者青睐，尤其是那些富含维生素、矿物质、中药材等具有营养、辅助保健效果成分的固体饮料，可以及时补充人体代谢所需营养，更成为了许多人生活中离不开的好伴侣。国家公布了药食同源物品，固体饮料可以添加中药材，用于制作保健食品，满足人民日益需求的食补，固体饮料迎来了发展良机。
发明内容
本发明的目的是提供一种组方简单，排酸、降酸、溶结石、调节酸碱平衡效果的葵花盘固体饮料。
本发明的技术解决方案：一种能排酸降酸溶结石调节酸碱平衡的葵花盘固体饮料，其特征在于其有效成分由以下重量份数的原料制成：葵花盘40份—50份，淡竹叶20份—30份，小蓟20—30份，赤藓糖醇5份。组方中各成份协作用具有源头降尿酸、护肾排尿酸、溶结石、抗炎消肿镇痛、调控嘌呤代谢、调节人体内酸碱平衡的作用。
优选但不限于：一种能抗菌解热止血的葵花盘固体饮料，其特征在于由以下重量份数的原料制成：葵花盘50份，淡竹叶20份，小蓟25份，赤藓糖醇5份。
制备方法：将上述原料经清洗、提取、过滤、浓缩、干燥、粉碎后添加赤藓糖醇后混匀，分装制成葵花盘固体饮料。
葵花盘主要成分是小分子肽、黄酮、多糖、生物碱等，药理实验表明，黄酮具有很强的的抗氧化性，可有效清除体内的氧自由基，抑制核酸的氧化；抑制嘌呤代谢酶，降低嘌呤含量，减少尿酸的产生。黄酮可以降低10%-20%血糖和30%-40%的甘油三酯，减轻肾脏细胞压力；稳定肾蛋白小管；有利于肾脏代谢尿酸。黄酮还可以抑制炎性生物酶的渗出，起到止痛的作用。生物碱是利用现代生物技术从葵花盘海绵体提取，葵花碱分子成分会与尿酸中和成盐而溶于血液，提高血液溶解尿酸盐的饱和度，有效的降低尿酸值，当尿酸含量下降后，血液流动就会溶解沉积在关节的痛风石，使其溶解，回到血液，并使多余的尿酸通过肾脏由尿液排出体外，达到降尿酸、排尿酸、溶解痛风石使其溶解成液态盐通过肾脏排出体外的效果。
淡竹叶主要成分是黄酮类、挥发性成分、三萜类及酚酸类等，具有抗菌、抗氧化、保肝、收缩血管、抗病毒、降血脂、保护心肌细胞等药理活性。功效清热除烦，利尿通淋。
小蓟主要成分是芸香苷、原儿茶酸、绿原酸、咖啡酸、甾醇类等，具有升压止血、抗突变、抗菌等药理作用。
赤藓糖醇作为食品添加剂加入其中。
组方中葵花盘与淡竹叶协同作用能够增强利尿、止血、抗氧化作用，淡竹叶与小蓟协同作用能够增强升压作用。组方中各成份协作用具有源头降尿酸、护肾排尿酸、溶结石、抗炎消肿镇痛、调控嘌呤代谢、调节人体内酸碱平衡的作用。
本发明剂型不限于此，还可制成颗粒剂、散剂、胶囊剂或其它保健食品领域常规制剂。
功效：排酸、降酸、溶结石、调节酸碱平衡。
用法用量：每次一包,每包10克-15克。
适用人群：需要降低血尿酸，溶解结石的亚健康人群。
本发明的优点是：1.组方、制备简单，成本低。2.配方具有可食性，无毒副作用，安全、可靠。3、具有抗菌解热止痛止血等辅助作用，能够使血压血脂恢复正常。葵花盘可以有效地降低血尿酸，溶解结石，去除痛风。4、经累计统计90名血尿酸偏高，有结石的人群服用，有效率100％。
下面将结合实施例对本发明的实施方式作进一步详细描述。
具体实施方式
实施例1
一种能抗菌解热止血的葵花盘固体饮料，其特征在于由以下重量份数的原料制成：葵花盘50份，淡竹叶20份，小蓟25份，赤藓糖醇5份。
试验例
1.对葵花盘的实验研究结果
吉林大学生命科学学院对小鼠进行抗炎实验，醋酸刺激小鼠导致小鼠腹腔毛细血管通透性增加，当葵花盘提取物小分子肽，黄酮给药剂量分别为300mg/kg,600mg/kg时有显著抑制作用，抑制率分别为74.78%和87.92%，另外对小鼠耳急性炎症早期的肿胀度有抑制作用，抑制率为46.47%和50.38%。
镇痛作用实验：给药组小鼠分别注射剂量为150、300、600mg/kg的葵花盘提取物，与空白对照组比较，结果表明，对于醋酸刺激所致的小鼠扭体次数，给药组明显低于对照组，抑制率分别为37.65%、67.83%、92.48%，呈一定比例关系。
2.对淡竹叶的实验研究结果
用柱色谱技术分离纯化淡竹叶中的黄酮苷成分，用滤纸片法考察抑菌活性，结果表明该成分对真菌、细菌均有一定的抑制作用。
3.对小蓟的实验研究结果
小蓟为传统中药，已证实其具有止血作用，小鼠口服浸剂5g/kg,其出血时间明显缩短。
上面描述，只是本发明的具体实施方式，各种举例说明不对本发明的实质内容构成限制。
Claims (2)
1.一种能排酸降酸溶结石调节酸碱平衡的葵花盘固体饮料，其特征在于其有效成分由以下重量份数的原料制成：葵花盘40份—50份，淡竹叶20份—30份，小蓟20—30份，赤藓糖醇5份。
2.按照权利要求1所述的能排酸降酸溶结石调节酸碱平衡的葵花盘固体饮料，其特征在于由以下重量份数的原料制成：葵花盘50份，淡竹叶20份，小蓟25份，赤藓糖醇5份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810288224.5A CN108522931A (zh) | 2018-03-30 | 2018-03-30 | 一种能排酸降酸溶结石调节酸碱平衡的葵花盘固体饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810288224.5A CN108522931A (zh) | 2018-03-30 | 2018-03-30 | 一种能排酸降酸溶结石调节酸碱平衡的葵花盘固体饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108522931A true CN108522931A (zh) | 2018-09-14 |
Family
ID=63482302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810288224.5A Pending CN108522931A (zh) | 2018-03-30 | 2018-03-30 | 一种能排酸降酸溶结石调节酸碱平衡的葵花盘固体饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108522931A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109169940A (zh) * | 2018-10-16 | 2019-01-11 | 南京果果食品有限公司 | 低嘌呤的豆浆饮品及其制备方法 |
| CN109833443A (zh) * | 2019-04-12 | 2019-06-04 | 中国农业科学院特产研究所 | 一种降低尿酸、缓解痛风的复合葵花盘组合物及其制备方法与应用 |
| CN110859304A (zh) * | 2019-11-26 | 2020-03-06 | 黑龙江惊哲森林食品集团有限公司 | 一种葵盘降嘌呤酵素及其制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107261009A (zh) * | 2017-08-02 | 2017-10-20 | 陈启康 | 米草稻秸秆配伍小蓟抗痛风茶及其制备方法 |
| CN107753801A (zh) * | 2017-12-06 | 2018-03-06 | 周勇 | 降尿酸、降嘌呤治疗痛风的药物组合物及其制备方法 |
-
2018
- 2018-03-30 CN CN201810288224.5A patent/CN108522931A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107261009A (zh) * | 2017-08-02 | 2017-10-20 | 陈启康 | 米草稻秸秆配伍小蓟抗痛风茶及其制备方法 |
| CN107753801A (zh) * | 2017-12-06 | 2018-03-06 | 周勇 | 降尿酸、降嘌呤治疗痛风的药物组合物及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 健康生活图书编委会编著: "《图解不生病的中医养生法》", 31 December 2010, 吉林科学技术出版社 * |
| 孙淑萍: "《家庭用药安全指南》", 31 May 2012, 安徽科学技术出版社 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109169940A (zh) * | 2018-10-16 | 2019-01-11 | 南京果果食品有限公司 | 低嘌呤的豆浆饮品及其制备方法 |
| CN109833443A (zh) * | 2019-04-12 | 2019-06-04 | 中国农业科学院特产研究所 | 一种降低尿酸、缓解痛风的复合葵花盘组合物及其制备方法与应用 |
| CN109833443B (zh) * | 2019-04-12 | 2021-07-27 | 中国农业科学院特产研究所 | 一种降低尿酸、缓解痛风的复合葵花盘组合物及其制备方法与应用 |
| CN110859304A (zh) * | 2019-11-26 | 2020-03-06 | 黑龙江惊哲森林食品集团有限公司 | 一种葵盘降嘌呤酵素及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shikov et al. | Medicinal plants of the Russian Pharmacopoeia; their history and applications | |
| Londhe et al. | Role of garlic (Allium sativum) in various diseases: An overview | |
| KR101074158B1 (ko) | 간 보호 또는 간 질환의 예방 및 치료용 인삼다당체 조성물 | |
| KR101594137B1 (ko) | 관절건강에 도움을 주는 건강기능식품 조성물 | |
| CN108522931A (zh) | 一种能排酸降酸溶结石调节酸碱平衡的葵花盘固体饮料 | |
| JP2003192605A (ja) | リパーゼ阻害剤 | |
| CN111919934A (zh) | 一种用于降三高保护心血管的红花苏心茶及其制备方法 | |
| CN107184966A (zh) | 一种防治糖尿病及其并发症的药物组合物 | |
| CN105250913B (zh) | 一种治疗蛋鸡脂肪肝综合症的药物组合物 | |
| CN101116497A (zh) | 复合蜂胶胶囊保健食品 | |
| CN104739964B (zh) | 一种蜗牛解酒制剂及其制作方法 | |
| CN110652552A (zh) | 一种伤口愈合配方及制备方法 | |
| CN1985917B (zh) | 用于降血糖、降血脂、控制糖尿病并发症的组合物 | |
| KR101491493B1 (ko) | 감귤 과피 및 구아바 추출물을 포함하는 항염증 약학 조성물 | |
| CN110063977B (zh) | 一种党参、沙棘复合冲剂及其应用 | |
| KR101529279B1 (ko) | 갓 추출물을 유효성분으로 함유하는 간독성 질환 예방 또는 치료용 약학 조성물 | |
| KR20080101848A (ko) | 숙취예방 및 해소를 위한 생약 추출물 및 이를 이용한 기능성 식품 | |
| KR100915893B1 (ko) | 숙취예방 및 해소를 위한 생약 추출물 및 이를 이용한 기능성 식품 | |
| Tchimene et al. | Anti-inflammatory property of the methanol leaf extract of Parinari kerstingii (ENGL) in rats | |
| CN105194023A (zh) | 高级戒烟含片 | |
| KR20050079913A (ko) | 헛개나무 추출물을 포함하는 비만 예방 및 치료를 위한조성물 | |
| KR101600745B1 (ko) | 생약 추출물을 포함하는 신경안정용 약학적 조성물 | |
| CN109010487A (zh) | 一种缓解小儿上呼吸道感染症状的口服液 | |
| CN113521195B (zh) | 一种用于酒精使用障碍的药食同源组合物及应用 | |
| CN110123859B (zh) | 具有防治肝损伤的菊叶提取物及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180914 |
|
| RJ01 | Rejection of invention patent application after publication |